Xeljanz Blood Clot Lawsuits | New FDA Warnings

Jan 9, 2018

Introduction to Xeljanz Blood Clot Lawsuits

Welcome to the page dedicated to providing comprehensive information about Xeljanz blood clot lawsuits. If you or a loved one have experienced severe side effects, such as blood clots, while using Xeljanz, you may be entitled to compensation.

About Xeljanz

Xeljanz is a medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It belongs to a class of drugs known as Janus kinase (JAK) inhibitors.

Xeljanz and Blood Clot Risks

Recent studies and reports have shown an increased risk of blood clots associated with the use of Xeljanz. The FDA has issued warnings regarding this potential side effect, highlighting the need for individuals using Xeljanz to be aware of the associated risks.

Understanding Xeljanz Blood Clot Lawsuits

Given the serious nature of blood clot risks linked to Xeljanz usage, numerous individuals who have suffered harm have sought legal recourse by filing Xeljanz blood clot lawsuits. These lawsuits aim to hold the pharmaceutical manufacturers accountable for their negligence and seek compensation for the damages caused.

Why You May Be Eligible for Compensation

If you or a loved one have experienced blood clots or other severe side effects while taking Xeljanz, you may be eligible to pursue financial compensation. These lawsuits seek to provide compensation for various damages, including but not limited to:

  • Medical expenses related to the treatment of blood clots caused by Xeljanz
  • Lost wages or loss of earning capacity due to the inability to work
  • Pain and suffering endured as a result of the complications
  • Emotional distress and psychological impact
  • Wrongful death claims in cases where the use of Xeljanz resulted in the death of a loved one

Proving Your Xeljanz Lawsuit

To successfully pursue a Xeljanz lawsuit, it is crucial to establish the following:

  1. Proof of Xeljanz usage and the occurrence of blood clot-related complications
  2. Linking the use of Xeljanz to the development of blood clots
  3. Evidence of the pharmaceutical company's negligence or failure to warn about the potential risks

The Role of John P. Bennett, Attorney at Law

John P. Bennett, Attorney at Law, is dedicated to representing individuals who have suffered harm due to the negligence of pharmaceutical companies. With our experience in handling complex drug liability lawsuits, we are here to help you navigate the legal process and fight for the compensation you deserve.

Contact Us Today

If you believe you have a Xeljanz blood clot lawsuit, don't hesitate to contact our knowledgeable team at John P. Bennett, Attorney at Law. We offer free consultations to evaluate your case and provide personalized legal guidance. Let us work to protect your rights and seek the justice you deserve.

David Sothan
Important warnings for Xeljanz users!
Nov 12, 2023
These FDA warnings highlight the importance of seeking compensation for Xeljanz blood clot injuries.
Oct 9, 2023